-
平臺(tái)編號(hào)：bio-69356
-
國(guó)際編號(hào)：CRL-2061?
-
細(xì)胞信息： SJRH30
-
規(guī)格：Frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
SJRH30
是否是腫瘤細(xì)胞：1
物種來(lái)源：人
年限：17 years
運(yùn)輸方式：凍存運(yùn)輸
數(shù)量：大量
組織來(lái)源：muscle
細(xì)胞形態(tài)：成纖維樣
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
ATCC Number：CRL-2061?
相關(guān)疾?。簷M紋肌肉瘤
規(guī)格：10 μg Designations: SJCRH30 [RC13, RMS 13, SJRH30]
Depositors: ?DN Shapiro
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Homo sapiens
Morphology:fibroblast
Source: Tissue: muscle
Disease: rhabdomyosarcoma
Derived from metastatic site: bone marrow
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Oncogene:gli + (amplified 30 fold), N-myc + (not amplified)
DNA Profile (STR):D5S818: 12, 13
D13S317: 11
D7S820: 10
D16S539: 12
THO1: 9, 9.3
TPOX: 8, 11
vWA: 17, 18
CSF1PO: 10, 11
Amelogenin: XY
Age: 17 years
Gender: male
Ethnicity: Caucasian
Comments:The line was established from cells from the bone marrow of a child with rhabdomyosarcoma.
The cells show ultrastructural elements of primitive skeletal muscle differentiation.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:5 to 1:10 is recommended
Medium Renewal: Twice per week
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Preservation: Culture medium, 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 22379: Oliner JD, et al. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992. PubMed: 1614537
23076: Roberts WM, et al. Amplification of the gli gene in childhood sarcomas. Cancer Res. 49: 5407-5413, 1989. PubMed: 2766305
23518: Douglass EC, et al. A specific chromosomal abnormality in rhabdomyosarcoma [published erratum appears in Cytogenet Cell Genet 1988;47(4):following 232]. Cytogenet. Cell Genet. 45: 148-155, 1987. PubMed: 3691179
物種來(lái)源：人
年限：17 years
運(yùn)輸方式：凍存運(yùn)輸
數(shù)量：大量
組織來(lái)源：muscle
細(xì)胞形態(tài)：成纖維樣
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
ATCC Number：CRL-2061?
相關(guān)疾?。簷M紋肌肉瘤
規(guī)格：10 μg Designations: SJCRH30 [RC13, RMS 13, SJRH30]
Depositors: ?DN Shapiro
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Homo sapiens
Morphology:fibroblast
Source: Tissue: muscle
Disease: rhabdomyosarcoma
Derived from metastatic site: bone marrow
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Oncogene:gli + (amplified 30 fold), N-myc + (not amplified)
DNA Profile (STR):D5S818: 12, 13
D13S317: 11
D7S820: 10
D16S539: 12
THO1: 9, 9.3
TPOX: 8, 11
vWA: 17, 18
CSF1PO: 10, 11
Amelogenin: XY
Age: 17 years
Gender: male
Ethnicity: Caucasian
Comments:The line was established from cells from the bone marrow of a child with rhabdomyosarcoma.
The cells show ultrastructural elements of primitive skeletal muscle differentiation.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:5 to 1:10 is recommended
Medium Renewal: Twice per week
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Preservation: Culture medium, 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 22379: Oliner JD, et al. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992. PubMed: 1614537
23076: Roberts WM, et al. Amplification of the gli gene in childhood sarcomas. Cancer Res. 49: 5407-5413, 1989. PubMed: 2766305
23518: Douglass EC, et al. A specific chromosomal abnormality in rhabdomyosarcoma [published erratum appears in Cytogenet Cell Genet 1988;47(4):following 232]. Cytogenet. Cell Genet. 45: 148-155, 1987. PubMed: 3691179
